SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
2496636
Source:
http://linkedlifedata.com/resource/pubmed/id/2496636
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0015506
,
umls-concept:C0021079
,
umls-concept:C0205195
,
umls-concept:C0368953
,
umls-concept:C0439661
,
umls-concept:C0574032
pubmed:issue
10
pubmed:dateCreated
1989-5-26
pubmed:abstractText
To evaluate the effectiveness of combined cyclophosphamide, vincristine, and prednisone (CVP) therapy after antigenic stimulation with factor VIII in the eradication of factor VIII inhibitor.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/R01HL27007
,
http://linkedlifedata.com/resource/pubmed/grant/RR05363
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2496636-2105074
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2496636-8239240
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Factor VIII
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone
,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0003-4819
pubmed:author
pubmed-author:ChiuA YAY
,
pubmed-author:LarcadaA FAF
,
pubmed-author:LianE CEC
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
110
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
774-8
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:2496636-Adult
,
pubmed-meshheading:2496636-Aged
,
pubmed-meshheading:2496636-Autoimmune Diseases
,
pubmed-meshheading:2496636-Cyclophosphamide
,
pubmed-meshheading:2496636-Drug Administration Schedule
,
pubmed-meshheading:2496636-Drug Therapy, Combination
,
pubmed-meshheading:2496636-Factor VIII
,
pubmed-meshheading:2496636-Female
,
pubmed-meshheading:2496636-Hemophilia A
,
pubmed-meshheading:2496636-Hemorrhagic Disorders
,
pubmed-meshheading:2496636-Humans
,
pubmed-meshheading:2496636-Immunosuppressive Agents
,
pubmed-meshheading:2496636-Male
,
pubmed-meshheading:2496636-Middle Aged
,
pubmed-meshheading:2496636-Prednisone
,
pubmed-meshheading:2496636-Vincristine
pubmed:year
1989
pubmed:articleTitle
Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor.
pubmed:affiliation
University of Miami School of Medicine, Florida.
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, U.S. Gov't, Non-P.H.S.
,
Case Reports